Stay updated with breaking news from Michaelj Mcbreen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Thomson Reuters consensus EPS estimate of $3.47. The company issued revenue guidance of $2.1 billion-$2.2 billion, compared to the consensus revenue estimate of $2.15 billion. The company updated its FY2023 earnings and revenue guidance.
Integra LifeSciences (NASDAQ:IART – Get Rating) had its price objective cut by Truist Financial from $54.00 to $44.00 in a report published on Tuesday morning, The Fly reports. A number of other equities analysts have also recently weighed in on IART. TheStreet cut Integra LifeSciences from a b- rating to a c+ rating in a […]
Citigroup downgraded shares of Integra LifeSciences (NASDAQ:IART – Get Rating) from a neutral rating to a sell rating in a research note issued to investors on Tuesday, The Fly reports. Citigroup currently has $39.00 price objective on the life sciences company’s stock, down from their previous price objective of $59.00. Several other brokerages also recently […]
Dimensional Fund Advisors LP decreased its holdings in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Rating) by 5.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,203,527 shares of the life sciences company’s stock after selling 71,407 shares […]
22nd Century Group reaffirmed their downgrade rating on shares of Integra LifeSciences (NASDAQ:IART – Get Rating) in a report published on Tuesday morning, Benzinga reports. Several other equities research analysts have also recently commented on IART. Citigroup cut Integra LifeSciences from a neutral rating to a sell rating and lowered their price target for the […]